Abstra ct. Hyperglycemia has been shown to induce arterial hypoxemia in the chronically catheterized fetal sheep. To investigate the mechanism behind this glucose-induced hypoxemia, eight pregnant ewes and their fetuses were studied. Fetal glucose infusion (1 1.9±0.6 mg glucose/kg per min) was associated with a doubling of the fetal plasma glucose concentration with concomitant elevation of the umbilical vein-distal arterial 02 content difference by 24 h of infusion (P < 0.01). Calculated fetal 02 consumption increased from 8.1±0.4 ml/kg per min in the control period to a maximum value of 10.6±0.3 ml/kg per min by third infusion day (P < 0.01), which is an increase of -30%. The degree of stimulation of fetal 02 consumption was related to the degree of fetal hyperglycemia but not to the degree of fetal hyperinsulinemia. The increase in fetal 02 consumption was accompanied by a significant increase in fetal 02 extraction with no change in either fetal 02 delivery or fetal blood 02 affinity. In addition, fetal hypercapnea with a mild fetal respiratory acidosis was induced by fetal hyperglycemia. The increase in fetal arterial Pco2 was linearly related (P < 0.001) to the magnitude of increase in fetal 02 consumption. These studies suggest that chronic fetal hyperglycemia induces a state ofaccelerated fetal oxidative metabolism and may be important in explaining the etiology behind certain unusual findings in human infants of diabetic mothers.
Introduction
The classical findings ofmacrosomia and postnatal hypoglycemia in newborn infants born to women with diabetes mellitus are thought to be due to the excesses in substrate uptake and insulin secretion ofthe fetus (1, 2) . However, certain clinical and pathological findings suggest that other disorders seen in these infants, such as polycythemia, hyperbilirubinemia, and late fetal demise (2, 3) , may be related to occult in utero hypoxemia. Using a chronically catheterized fetal lamb preparation, it has recently been demonstrated that long-term fetal glucose infusion induces a relative fetal arterial hypoxemia (4) , and that the degree of this hypoxemia is related to the magnitude of the hyperglycemia. It has been unclear whether or not this glucose-induced hypoxemia is secondary to abnormalities in uterine and/or fetal oxidative metabolism or is simply due to altered placental gas transport. The purpose of the current study was to investigate each of these possible etiologies using the fetal lamb model with chronic defined fetal glucose infusions.
Methods
Surgical preparation. Eight pregnant ewes were studied between 120 and 140-d gestation (term gestation in the sheep is -150 d). Five had singleton pregnancies. Preoperatively, all ewes were anesthetized with intravenous sodium pentobarbital and intrathecal pontocaine. At hysterotomy, polyvinyl chloride catheters were implanted into the fetal distal aorta (postductal) and inferior vena cava using a pedal approach. Of the three twin gestations, only one fetal twin from each was catheterized. Umbilical venous catheters were inserted directly into the common umbilical vein (5) or into a cotyledonary branch and advanced proximally until the catheter tip was in the common umbilical vein. Maternal catheters were placed in the distal aorta via a femoral insertion and into the common uterine vein of the pregnant uterine horn (5) . An amniotic space catheter was inserted for pressure monitoring and instillation ofantibiotics. All catheters were then tunnelled subcutaneously to a pouch on the ewe's flank. Catheter tip placement was confirmed at autopsy in the majority of preparations and was adequate in all. A 4-5-d postoperative recovery period was allowed prior to experimentation. Postoperative management was performed as previously described (6) . All animals were housed in individual carts for the duration of the experimental protocol and allowed food and water ad libitum.
Experimental protocol. During a control period of 2 d, fetal and maternal arterial blood samples were obtained for plasma concentrations of glucose and insulin as well as arterial blood gases (pH, Pco2 and Po2), hematocrit, and serum solids. Twice daily, samples were drawn simultaneously from the uterine vein and maternal aorta, and the umbilical vein and fetal distal aorta to assess venoarterial blood concentration differences of oxygen (02) across the uterine and umbilical circulations. Uterine and umbilical blood flows were also measured twice daily using the antipyrine steady state diffusion technique (7) . Uterine and fetal 02 consumptions (Qo2)' were calculated from the Fick Principle as the product of the respective blood flow and arteriovenous 02 content difference measurements. Uteroplacental 02 consumption was derived as the difference between uterine and fetal Qo2's. Fetal 02 delivery was calculated as the product of umbilical blood flow and umbilical venous 02 content. Fetal 02 extraction was calculated as the ratio between fetal 02 consumption and fetal 02 delivery.
At the end ofthe 2-d control period, fetal glucose infusion was begun at a rate of 12.5 mg glucose/kg estimated fetal weight per min and continued for 72 h. A solution of 50% glucose in sterile water was infused into the fetal vena caval catheter using precalibrated syringe pumps (Orion Research Products, Cambridge, MA; Harvard Apparatus Co., South Natick, MA). These infusions resulted in infusate delivery rates between 3 and 6 ml/h. At daily intervals beginning 24 h after the commencement of fetal glucose infusion, venoarterial sampling across the uterine and umbilical circulations was performed twice for estimation of blood flow, blood 02 content, and calculation of 02 consumption.
Since the determination of the rate of fetal weight gain with advancing gestational age was impossible during the experiments, the estimates of fetal oxygen consumption were calculated arbitrarily using the estimated preinfusion weight for control and experimental values alike. Fetal weight increases by -2-4%/d in late gestation (8) and some, but not proportionate, increases in fetal oxygen consumption (expressed as ml/min) also occur after 120-130-d gestation (9, 10 were withdrawn into capillary tubes pretreated with NaF. Plasma antipyrine concentrations were determined using the Technicon Autoanalyzer (Technicon Instruments Corp., Tarrytown, NY). Arterial blood gases were measured using a Corning #178 Blood Gas Analyzer (Corning Medical Products, Medfield, MA). P50 measurements were performed at 370C and utilized a tonometric method (IL237 tonometer; Instrumentation Laboratory, Inc., Lexington, MA). Fetal erythrocyte 2,3-DPG concentrations were measured using the enzymatic method of Keitt (I 1). Plasma insulin concentrations were determined using a modified insulin radioimmunoassay (6) Statistical methods. All results are expressed as mean± I SEM. Statistical significance was assessed using the paired Student's t test and two-way analyses ofvariance. Linear regression analyses were performed using the least squares method.
Results
Nine separate glucose infusions were performed in the fetal lambs. Glucose infusion rates were 11.9±0.6 mg glucose/kg per min when corrected for known fetal delivery weights. As shown in Fig. 1 , fetal glucose infusion resulted in a sustained increase in fetal plasma arterial glucose concentration from 26.0±1.9 to 58.8±3.7 mg/dl during the 72-h infusion period (P < 0.001). Umbilical venous 02 content fell slightly from 10.7±0.6 to 9.2±0.9 mg/dl, but the change was not statistically significant.
In contrast, fetal distal aortic 02 content fell from the basal value of 7.3±0.5 to 5.7±0.4 ml/dl by 24 h ofinfusion (P < 0.01) and reached a nadir of 4.9±0.7 ml/dl (2.2±0.4 ml/dl below base line) by the third day of glucose infusion (P < 0.01). Consequently, fetal hyperglycemia induced a rise in the umbilical venoarterial 02 content difference by 24 h of infusion (from 3.5±0.2 to 4.3±0.2 ml/dl, P < 0.01). The elevation in umbilical (venoarterial) 02 content was maintained throughout the experimental period (Fig. 1) .
Glucose infusion produced no alteration in umbilical blood flow from the basal value of 232±7 ml/kg per min (828±25 ml/min 186±7 (8) 69±3 (8) 30±3 (8) 0.19±0.03 (8) 0.14±0.02 (8) Day 1 394±34 (7) 219±11 (8) 203±11 (8) 70±5 (7) 29±2 (8) 0.19±0.03 (7) 0.13±0.02 (7) Day 2 396±37 (7) 223±13 (8) 197±10 (8) 67±4 (7) 31±3 (7) 0.18±0.03 (7) 0.14±0.02 (6) Day 3 416±67 (5) 241±15 (7) 197±12 (7) 71±4 (5) 32±3 (5) 0.20±0.05 (5) 0.13±0.01 (6) ut, uterine; umb, umbilical. *, ( ), number of observations.
to a similar degree as the uterine Qo2 (from 29.4±3 to 38.5±4.1 ml/min by, day 3 of glucose infusion, P < 0.05), and thus, no change in the calculated uteroplacental Qo2 was noted from the basal value of 21.6±2.6 ml/min. Fetal hyperglycemia induced no alterations in fetal heart rate nor in fetal or maternal blood pressures (Table II) . In addition, no changes were seen in uterine or umbilical vascular resistances. No changes in fetal hematocrit nor in total serum solids were detected (Table III) . The 50% hemoglobin-02 saturation point (P50) of fetal distal arterial blood was determined during five of the infusions (Table III) . Hyperglycemia did not change the basal P5o of 15.8±0.6 torr. In four experiments, fetal Difference from control: *, P < 0.05; f, P < 0.01. erythrocyte 2,3-DPG concentrations were determined as well and were unaltered by chronic hyperglycemia. Fetal arterial blood gases assessed daily showed significant changes during hyperglycemia (Table III) . As expected, arterial P02 fell significantly (P < 0.01) by 48 h of glucose infusion.
Arterial Pco2 rose significantly by 24 h of glucose infusion and remained elevated throughout the experimental period, although this elevation was significant on days 1 and 2 only. This hypercapnea was accompanied by a significant fall in pH on day 1 with a subsequent increase in calculated buffer base noted on day 2. The sum total of events indicated an early respiratory acidosis induced by hyperglycemia, with later metabolic compensation and an ongoing arterial hypoxemia. No changes in maternal pH or P02 were noted during the experimental period from control. Maternal arterial Pco2 during the control period was 32.6±1.5 torr and did not change significantly during days 1 and 2 of fetal glucose infusion. A small but statistically significant decrease in Pco2 to 30.3±1.2 torr (P < 0.02) was noted on day 3 of infusion. When the fetal PCo2 data were related to changes in fetal Qo2, no relationship was apparent because of interanimal variability in both parameters. However, when fetal Qo2's were expressed as percent from control and fetal Pco2's expressed as fetomaternal ratios to decrease this variability, a relationship is apparent (Fig. 4) coefficient. Although a significant relationship (P < 0.001) was noted between the rise in fetal plasma glucose and the simultaneously sampled plasma insulin concentration (Fig. 5) , no relationship was noted between fetal insulin concentrations and fetal Qo2 before and during hyperglycemia. No changes in maternal glucose concentrations were observed during the experimental period.
Discussion
Previous work using the chronically catheterized fetal lamb model has demonstrated that chronic fetal hyperglycemia is associated with significant distal arterial hypoxemia and a mild arterial hypercapnea (4). With pronounced hyperglycemia, progressive hypoxia, metabolic acidosis, and fetal demise were evident. Although a linear relationship was apparent between the degree of hyperglycemia and the relative fall in fetal arterial 02 content, the mechanism behind the fetal hypoxemia was unclear.
Major hypotheses to explain these alterations included either stimulation of fetal and/or uteroplacental 02 consumption or depression of transplacental 02 transport due either to decreased 02 diffusion or altered fetal hemoglobin-02 affinity.
The present data may be interpreted to indicate that the development of hyperglycemia in the fetal lamb induces an acceleration of the fetal metabolic rate and that the increase in fetal 02 consumption is almost wholly responsible for the observed fall in preplacental arterial 02 content. Although hyperglycemia has been shown to alter hemoglobin-02 affinity in diabetic states (12) , no changes in fetal hemoglobin-02 affinity or fetal erythrocyte 2,3-DPG concentrations were observed. In addition, no changes in monitored vascular parameters were noted to account for the above mentioned changes in fetal 02 content.
In further studies using this model (13) , concomitant increases in glucose and lactate uptake have been demonstrated during fetal hyperglycemia. It is of particular interest that significant increases in fetal glucose entry rate as well as fetal 02 consumption occurred. Such accelerated oxidative metabolism would be expected to be accompanied by increased fetal CO2 excretion. The small but significant elevation in preplacental arterial Pco2 is suggestive evidence for accelerated CO2 excretion since it is unlikely that transplacental CO2 diffusion would be 283 Chronic Hyperglycemia in Fetal Lamb I lbo significantly altered in the face of norial 02 diffusion and stable umbilical and uterine blood flows (14, 15) . From the theoretical model oftransplacental CO2 diffusion derived by Hill et al. (15) , the observed rise of 3.8 to 4.4 torr in fetal arterial PCo2 would be associated with a 20-30% increase in fetomaternal CO2 transfer. The observed change in fetal arterial Pco2 could not be accounted for by changes in maternal CO2 tension, which were stable to decreased during the experimental period.
Some precedent exists to suggest that the fetal metabolic rate may be altered under experimental conditions. Lorijn and Longo (16, 17) have demonstrated significant stimulation of 02 consumption in fetal lambs using direct fetal infusions of norepinephrine or triiodothyronine. In addition, other recent work (18, 19) suggests that acceleration of fetal oxidative metabolism may also occur during fetal insulin infusion. The increase was effected by widening of the umbilical venoarterial 02 content difference without change in umbilical blood flow although significant increases in cardiac output occurred. In the insulin infusion studies, pharmacologic doses of insulin were used and fetal insulin concentrations were generally 2-20-fold above the range seen with the endogenous hyperinsulinemia observed in the present series of experiments. Since in the fetal state, alterations in cardiac output relate more to change in heart rate than stroke volume (20) , the absence of significant fetal tachycardia in the chronically hyperglycemic fetal lamb suggests that little increases in cardiac output of the type seen with exogenous insulin infusion occurred. This finding, in addition to the lack of a significant relationship between fetal plasma insulin concentration and either the degree of arterial hypoxemia (4) (25) . In addition, ingestion of a carbohydrate meal in fasting adults resulted in increases in both 02 consumption and CO2 excretion (26) . Several other studies in adult humans supported with parenteral nutrition have tended to confirm the observation that substrate excess induces acceleration of metabolic rate. In studies utilizing parenteral infusions of glucose and amino acids with or without supplemental fat, significant enhancement of alveolar ventilation, 02 consumption, and CO2 excretion were noted when compared with control (27) (28) (29) . In one case, these resultant increases were so great that they were detrimental to the patient under study (30) .
No data are available at present to indicate the metabolic goal of increased fetal metabolism found in the present study. is of interest to note that Rurak et al. (32) recently observed that normal fetal respiratory movements can account for up to 17% of the fetal 02 consumption rate. Several authors (33, 34) have documented stimulation of fetal breathing by hyperglycemia in fetal lambs and humans, and thus, giving rise to the possibility that stimulation of muscular work may be in part responsible for the observed increases in fetal Qo2. Alternatively, it has been hypothesized (33) that these increases in fetal breathing movements are due to accelerated glucose-induced fetal CO2 production with consequent respiratory center stimulation. Other possible mechanisms for a glucose-induced increase in fetal oxidative metabolism include excessive heat production (35), acceleration offetal growth, and stimulation of futile cycling within some fetal tissues (36) .
No direct information is available from human fetuses or infants of diabetic mothers (IDM's) to support the hypothesis that fetal hyperglycemia induces changes similar to those seen in fetal lambs. MacKay (37) noted a marked umbilical arterial hypoxemia in a small number of IDM's at delivery in the only study available in which 02 content was measured in umbilical vessels. Naeye (38) 
